Johnson & Johnson vs Labcorp Holdings Inc.
JNJ vs LH — side-by-side comparison from reported financials. JNJ leads 7, LH leads 3 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Labcorp Holdings Inc.
LH · Healthcare
$311.84-0.75%Solid
| Metric | JNJ | LH |
|---|---|---|
| Price | $261.79 | $311.84 |
| Market cap | $631B | $25.3B |
| Revenue (TTM) | $97.9B | $14.3B |
| Revenue growth | +5.6% | +5.5% |
| Net margin | 21.5% | 7.0% |
| Free cash flow | $22.2B | $1.16B |
| Net cash (debt) | ($27.8B) | ($4.55B) |
| 1-year price return | +37.0% | +12.3% |
| P/E | 29.9 | 25.3 |
| P/E vs own history (cheap-side %) | 16% | 51% |
| Dividend yield | 2.00% | 0.94% |
| Return on equity | 26% | 12% |
| Altman Z-score | — | 2.86 |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 71,000 |
Full résumé-style profiles: JNJ CV · LH CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.